| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_202c0ae13d6e6d191976fd3f0c6e5388 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4725 |
| filingDate |
2014-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_69d98ff62d5a88b5852bda6f6d880e2a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6e8bf29fea9f470fbed357531a9a7be2 |
| publicationDate |
2016-05-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2016079102-A |
| titleOfInvention |
Solifenacin-containing preparation |
| abstract |
Disclosed is a solifenacin-containing preparation which is obtained by a simple method and does not feel bitterness at the time of taking in a preparation containing solifenacin or a pharmaceutically acceptable salt thereof without coating a bitter taste masking agent. about. A solifenacin-containing preparation comprising solifenacin or a pharmaceutically acceptable salt thereof and a metal chloride, and solifenacin or a pharmaceutically acceptable salt thereof and a metal chloride. A method for producing a solifenacin-containing preparation characterized by the above. [Selection figure] None |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2018039780-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20200144127-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019208540-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-7361833-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2018012697-A |
| priorityDate |
2014-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |